A Randomized, Prospective, Open Label, Multicentre Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
This is a randomized, prospective, open label, multicentre study to assess the safety and
utility of PINPOINT® Near Infrared Fluorescence Imaging (PINPOINT) in identification of
lymph nodes (LN) in patients with uterine and cervical malignancies who are undergoing LN
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society